P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Luo, J ^a,b   Lee, S ^a,c   Wu, D ^a   Yeh, J ^a,d   Ellamushi, H ^a,d   Wheeler, A P ^a   Warnes, G ^a   Bo, X ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Semyung University   (South Korea)

^d Department of Neurosurgery ^*  (United Kingdom)

Author keywords

ATP receptor; Cell death; Cell transplantation; Purinoceptor; Schwann cell; Spinal cord injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINERGIC P2X7 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CHANNEL GATING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; MYELIN SHEATH; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE; SPINAL CORD; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELL DEATH; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; ENDOCYTOSIS; ETHIDIUM; HUMANS; INTRACELLULAR SPACE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PURINERGIC P2X RECEPTOR ANTAGONISTS; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2X7; SCHWANN CELLS; SCIATIC NERVE; SPINAL CORD; TETRAZOLES;

EID: 84887436299     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.343     Document Type: Article

References (44)

1. Fortun J, Hill CE, Bunge MB. Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett 2009; 456: 124-132
2. Hill CE, Moon LD, Wood PM, Bunge MB. Labeled Schwann cell transplantation: Cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia 2006; 53: 338-343
3. Pearse DD, Sanchez AR, Pereira FC, Andrade CM, Puzis R, Pressman Y et al. Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia 2007; 55: 976-1000
4. Haider H, Ashraf M. Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 2008; 45: 554-566
5. Fields RD, Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 2006; 7: 423-436
6. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006; 442: 527-532
7. Newman EA. Propagation of intercellular calcium waves in retinal astrocytes and Muller cells. J Neurosci 2001; 21: 2215-2223
8. Dou Y, Wu HJ, Li HQ, Qin S, Wang YE, Li J et al. Microglial migration mediated by ATPinduced ATP release from lysosomes. Cell Res 2012; 22: 1022-1033
9. Domercq M, Perez-Samartin A, Aparicio D, Alberdi E, Pampliega O, Matute C. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 2010; 58: 730-740
10. Virginio C, MacKenzie A, North RA, Surprenant A. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 1999; 519: 335-346
11. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013-1067
12. Volonte C, Apolloni S, Skaper SD, Burnstock G. P2X7 receptors: Channels, pores and more. CNS Neurol Disord Drug Targets 2012; 11: 705-721
13. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996; 272: 735-738
14. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di Virgilio F. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 1995; 95: 1207-1216
15. Coutinho-Silva R, Persechini PM, Bisaggio RD, Perfettini JL, Neto AC, Kanellopoulos JMet al. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 1999; 276: C1139-C1147
16. Sperlagh B, Vizi ES, Wirkner K, Illes P. P2X7 receptors in the nervous system. Prog Neurobiol 2006; 78: 327-346
17. Matute C. P2X7 receptors in oligodendrocytes: A novel target for neuroprotection. Mol Neurobiol 2008; 38: 123-128
18. Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 2001; 21: 7143-7152
19. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Collo G, Buell G et al. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 1997; 36: 1295-1301
20. Notomi S, Hisatomi T, Kanemaru T, Takeda A, Ikeda Y, Enaida H et al. Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death. Am J Pathol 2011; 179: 2798-2809
21. Delarasse C, Gonnord P, Galante M, Auger R, Daniel H, Motta I et al. Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor. J Neurochem 2009; 109: 846-857
22. Colomar A, Amedee T. ATP stimulation of P2X(7) receptors activates three different ionic conductances on cultured mouse Schwann cells. Eur J Neurosci 2001; 14: 927-936
23. Di Virgilio F. Novel data point to a broader mechanism of action of oxidized ATP: The P2X7 receptor is not the only target. Br J Pharmacol 2003; 140: 441-443
24. Beigi RD, Kertesy SB, Aquilina G, Dubyak GR. Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br J Pharmacol 2003; 140: 507-519
25. Nelson DW, Gregg RJ, Kort ME, Perez-Medrano A, Voight EA, Wang Y et al. Structureactivity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J Med Chem 2006; 49: 3659-3666
26. Lyons SA, Morell P, McCarthy KD. Schwann cells exhibit P2Y purinergic receptors that regulate intracellular calcium and are up-regulated by cyclic AMP analogues. J Neurochem 1994; 63: 552-560
27. Grafe P, Mayer C, Takigawa T, Kamleiter M, Sanchez-Brandelik R. Confocal calcium imaging reveals an ionotropic P2 nucleotide receptor in the paranodal membrane of rat Schwann cells. J Physiol 1999; 515: 377-383
28. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004; 10: 821-827
29. Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS. Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 2011; 63: 641-683
30. Beis I, Newsholme EA. The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J 1975; 152: 23-32
31. Easterbrook-Smith SB, Wallace JC, Keech DB. Pyruvate carboxylase: Affinity labelling of the magnesium adenosine triphosphate binding site. Eur J Biochem 1976; 62: 125-130
32. Craighead MW, Middlehurst KM, LeFeuvre R, Kimber I, Rothwell NJ. Oxidised adenosine 5'-Triphosphate, a P2X(7) antagonist, is toxic to rat cerebellar granule neurones in vitro. Neurosci Lett 2001; 311: 77-80
33. Schneider EM, Vorlaender K, Ma X, Du W, Weiss M. Role of ATP in trauma-Associated cytokine release and apoptosis by P2X7 ion channel stimulation. Ann N Y Acad Sci 2006; 1090: 245-252
34. Le Feuvre R, Brough D, Rothwell N. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur J Pharmacol 2002; 447: 261-269
35. Skaper SD, Debetto P, Giusti P. The P2X7 purinergic receptor: From physiology to neurological disorders. FASEB J 2010; 24: 337-345
36. Franke H, Gunther A, Grosche J, Schmidt R, Rossner S, Reinhardt R et al. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol 2004; 63: 686-699
37. Narcisse L, Scemes E, Zhao Y, Lee SC, Brosnan CF. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 2005; 49: 245-258
38. John GR, Simpson JE, Woodroofe MN, Lee SC, Brosnan CF. Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: Implications for inflammatory gene expression. J Neurosci 2001; 21: 4134-4142
39. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T et al. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-Activated protein kinase. J Neurosci 2001; 21: 7135-7142
40. Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci USA 2009; 106: 12489-12493
41. Brockes JP, Fields KL, Raff MC. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 1979; 165: 105-118
42. Luo J, Bo X, Wu D, Yeh J, Richardson PM, Zhang Y. Promoting survival, migration, and integration of transplanted Schwann cells by over-expressing polysialic acid. Glia 2011; 59: 424-434
43. Zhang Y, Zhang X, Yeh J, Richardson P, Bo X. Engineered expression of polysialic acid enhances Purkinje cell axonal regeneration in L1/GAP-43 double transgenic mice. Eur J Neurosci 2007; 25: 351-361
44. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005; 114: 386-396